Windsor James Brian's Form 4 filing
Rein Therapeutics, Inc. (RNTX) · filed Nov 21, 2023
- Accession no.
- 0000950170-23-065545
- Filed
- Nov 21, 2023
- Trade date
- Nov 20, 2023
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market purchases total $10.0K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Windsor James BrianCIK 0001790933 | Officer (President and COO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 20, 2023 | Common Stock | PPurchaseAcquired | +5,076 | $1.97 | +$9,999.72 | 5,122 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.